Oruka Therapeutics, Inc. (ORKA) Free cash flow 2015–2025
Oruka Therapeutics, Inc. (ORKA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$88.4MFY2025 · since FY2015: -$10.5M → -$88.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$88.4M | — |
| FY2023 | -$5.0M | +54.1% |
| FY2022 | -$10.9M | +42.0% |
| FY2021 | -$18.8M | -142.8% |
| FY2020 | -$7.7M | -61.2% |
| FY2019 | -$4.8M | +41.7% |
| FY2018 | -$8.2M | +52.8% |
| FY2017 | -$17.5M | -16.5% |
| FY2016 | -$15.0M | -42.2% |
| FY2015 | -$10.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice